Common Variable Immunodeficiency (CVID): Clinical Trials

1 completed. 1 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	1	Completed 1

Follow Common Variable Immunodeficiency (CVID): new trials by email Literature Review of Common Variable Immunodeficiency (CVID) trials Research Report on Common Variable Immunodeficiency (CVID)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
The Rifaximin Study in CVID Rifaximin - Common Variable Immunodeficiency (CVID)	Phase 4	Completed	Oslo University Hospital	40	2013-10-01	2015-04-24

Narrower conditions

Common Variable Immunodeficiency (1)

Broader conditions

Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)

Interventions

Rifaximin (1)

Sponsors

Oslo University Hospital (1)

Countries

Norway (1)

Top investigators

Borre Fevang, MD, Phd (1)